Loss of Spy1 decreases tumor onset and reduces the cancer stem cell population.<h4>Conclusions</h4>This data demonstrates the potential of Spy1 to expand mammary stem cell populations and contribute to the initiation and progression of aggressive, breast cancers with increased cancer stem cell populations. Here, SPDYA is linked to neoplasm.